Cargando…
Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995811/ https://www.ncbi.nlm.nih.gov/pubmed/33975869 http://dx.doi.org/10.1136/gutjnl-2021-324664 |
| _version_ | 1784684363076599808 |
|---|---|
| author | Marinoni, Ilaria |
| author_facet | Marinoni, Ilaria |
| author_sort | Marinoni, Ilaria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8995811 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89958112022-04-27 Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation? Marinoni, Ilaria Gut Commentary BMJ Publishing Group 2022-05 2021-05-11 /pmc/articles/PMC8995811/ /pubmed/33975869 http://dx.doi.org/10.1136/gutjnl-2021-324664 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Commentary Marinoni, Ilaria Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation? |
| title | Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation? |
| title_full | Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation? |
| title_fullStr | Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation? |
| title_full_unstemmed | Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation? |
| title_short | Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation? |
| title_sort | prognostic value of daxx/atrx loss of expression and alt activation in pannets: is it time for clinical implementation? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995811/ https://www.ncbi.nlm.nih.gov/pubmed/33975869 http://dx.doi.org/10.1136/gutjnl-2021-324664 |
| work_keys_str_mv | AT marinoniilaria prognosticvalueofdaxxatrxlossofexpressionandaltactivationinpannetsisittimeforclinicalimplementation |